157 related articles for article (PubMed ID: 2154510)
1. Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage.
Papagapiou MP; Auer RN
J Cereb Blood Flow Metab; 1990 Mar; 10(2):270-6. PubMed ID: 2154510
[TBL] [Abstract][Full Text] [Related]
2. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
3. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
Stevens MK; Yaksh TL
J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
[TBL] [Abstract][Full Text] [Related]
4. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil.
Warner MA; Neill KH; Nadler JV; Crain BJ
J Cereb Blood Flow Metab; 1991 Jul; 11(4):600-10. PubMed ID: 1828809
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats.
Vezzani A; Serafini R; Stasi MA; Caccia S; Conti I; Tridico RV; Samanin R
J Pharmacol Exp Ther; 1989 Apr; 249(1):278-83. PubMed ID: 2540317
[TBL] [Abstract][Full Text] [Related]
6. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
8. Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K; Enomoto R
J Pharmacol Exp Ther; 1991 Mar; 256(3):1161-72. PubMed ID: 1826032
[TBL] [Abstract][Full Text] [Related]
9. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
Goldberg MP; Viseskul V; Choi DW
J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
[TBL] [Abstract][Full Text] [Related]
10. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines.
Subramaniam S; McGonigle P
J Pharmacol Exp Ther; 1991 Feb; 256(2):811-9. PubMed ID: 1671602
[TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
Kurumaji A; Nehls DG; Park CK; McCulloch J
Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
Foster AC; Gill R; Woodruff GN
J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
[TBL] [Abstract][Full Text] [Related]
13. Effect of delayed MK-801 (dizocilpine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats.
Dietrich WD; Lin B; Globus MY; Green EJ; Ginsberg MD; Busto R
J Cereb Blood Flow Metab; 1995 Nov; 15(6):960-8. PubMed ID: 7593357
[TBL] [Abstract][Full Text] [Related]
14. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels.
Ramoa AS; Alkondon M; Aracava Y; Irons J; Lunt GG; Deshpande SS; Wonnacott S; Aronstam RS; Albuquerque EX
J Pharmacol Exp Ther; 1990 Jul; 254(1):71-82. PubMed ID: 1694895
[TBL] [Abstract][Full Text] [Related]
15. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.
Fix AS; Horn JW; Wightman KA; Johnson CA; Long GG; Storts RW; Farber N; Wozniak DF; Olney JW
Exp Neurol; 1993 Oct; 123(2):204-15. PubMed ID: 8405286
[TBL] [Abstract][Full Text] [Related]
16. Differential neuronal fates in the CA1 hippocampus after hypoxia in newborn and 7-day-old rats: effects of pre-treatment with MK-801.
Grojean S; Pourié G; Vert P; Daval JL
Hippocampus; 2003; 13(8):970-7. PubMed ID: 14750659
[TBL] [Abstract][Full Text] [Related]
17. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
Grigg JJ; Anderson EG
J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of N-methyl-D-aspartate receptors increases paraoxon-induced apoptosis in cultured neurons.
Wu X; Tian F; Okagaki P; Marini AM
Toxicol Appl Pharmacol; 2005 Oct; 208(1):57-67. PubMed ID: 16164961
[TBL] [Abstract][Full Text] [Related]
19. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
20. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
